We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFND
5626
DELISTED
Siren DIVCON Dividend Defender ETF
DFND
$192K ﹤0.01%
6,074
-6,358
-51% -$197K
TCDA
5627
CALL
DELISTED
Tricida, Inc. Common Stock
TCDA
$192K ﹤0.01%
+5,100
New +$190K
CVLG icon
5628
Covenant Logistics
CVLG
$872M
$191K ﹤0.01%
29,456
+10,120
+52% +$73.4K
MPLX icon
5629
PUT
MPLX
MPLX
$59.7B
$191K ﹤0.01%
7,500
-17,400
-70% -$443K
MRNS
5630
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$191K ﹤0.01%
22,022
+5,365
+32% +$30.1K
DBP icon
5631
Invesco DB Precious Metals Fund
DBP
$255M
$190K ﹤0.01%
4,555
-1,079
-19% -$44.4K
FARM
5632
DELISTED
Farmer Brothers
FARM
$190K ﹤0.01%
12,615
+11,043
+702% +$161K
MFIN icon
5633
Medallion Financial
MFIN
$250M
$190K ﹤0.01%
26,028
+5,691
+28% +$37.3K
TMFS icon
5634
Motley Fool Small-Cap Growth ETF
TMFS
$60.1M
$190K ﹤0.01%
7,399
+4,580
+162% +$111K
TREC
5635
DELISTED
Trecora Resources
TREC
$190K ﹤0.01%
26,551
+8,537
+47% +$69.8K
ELSE
5636
DELISTED
Electro-Sensors
ELSE
$189K ﹤0.01%
52,000
GURU icon
5637
Global X Guru Index ETF
GURU
$63.5M
$189K ﹤0.01%
5,240
EUHY
5638
iShares Euro High Yield Corporate Bond USD Hedged ETF
EUHY
$246M
$189K ﹤0.01%
3,639
+1,425
+64% +$72.7K
MD icon
5639
Pediatrix Medical
MD
$2.2B
$189K ﹤0.01%
6,811
-969
-12% -$24.3K
MRSH
5640
PUT
Marsh
MRSH
$91.5B
$189K ﹤0.01%
1,700
+300
+21% +$31.3K
LEVL
5641
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
$189K ﹤0.01%
7,504
+2,608
+53% +$64K
SYG
5642
DELISTED
SPDR MFS Systematic Growth Equity ETF of SSgA Active Trust
SYG
$189K ﹤0.01%
2,111
-98
-4% -$8.37K
CBAN icon
5643
Colony Bankcorp
CBAN
$467M
$188K ﹤0.01%
11,397
+4,126
+57% +$65.2K
CERS icon
5644
Cerus
CERS
$474M
$188K ﹤0.01%
44,595
-9,488
-18% -$40.9K
OSG
5645
DELISTED
Overseas Shipholding Group Inc.
OSG
$188K ﹤0.01%
81,706
+30,490
+60% +$56.7K
CRNC icon
5646
Cerence
CRNC
$414M
$187K ﹤0.01%
+8,275
New +$136K
VOXX
5647
DELISTED
VOXX International Corporation Class A
VOXX
$187K ﹤0.01%
42,866
-2,573
-6% -$11.9K
MYOV
5648
DELISTED
Myovant Sciences Ltd.
MYOV
$187K ﹤0.01%
12,035
+4,885
+68% +$49.2K
DHX icon
5649
DHI Group
DHX
$173M
$186K ﹤0.01%
61,835
+20,010
+48% +$68K
FLXS icon
5650
Flexsteel Industries
FLXS
$311M
$185K ﹤0.01%
9,270
+3,832
+70% +$66.8K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.